Segall Bryant & Hamill LLC Acquires 503,713 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Segall Bryant & Hamill LLC lifted its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 55.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,415,156 shares of the medical instruments supplier's stock after purchasing an additional 503,713 shares during the period. Segall Bryant & Hamill LLC owned 3.50% of AngioDynamics worth $12,963,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the business. SBI Securities Co. Ltd. bought a new stake in AngioDynamics in the 4th quarter valued at $28,000. R Squared Ltd acquired a new position in shares of AngioDynamics in the fourth quarter valued at $49,000. US Bancorp DE increased its holdings in AngioDynamics by 1,938.0% in the 4th quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier's stock valued at $61,000 after buying an additional 6,376 shares during the period. Quarry LP raised its stake in shares of AngioDynamics by 40.9% in the 3rd quarter. Quarry LP now owns 8,518 shares of the medical instruments supplier's stock valued at $66,000 after buying an additional 2,471 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in shares of AngioDynamics by 21.3% in the 4th quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier's stock valued at $147,000 after purchasing an additional 2,832 shares during the period. Institutional investors and hedge funds own 89.43% of the company's stock.

Insider Buying and Selling at AngioDynamics

In related news, SVP Warren Nighan, Jr. sold 4,060 shares of the firm's stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $12.31, for a total transaction of $49,978.60. Following the sale, the senior vice president now directly owns 41,817 shares in the company, valued at $514,767.27. This trade represents a 8.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 5.40% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, HC Wainwright upped their target price on shares of AngioDynamics from $14.00 to $15.00 and gave the company a "buy" rating in a research report on Friday, January 10th.

AngioDynamics Trading Down 3.4 %

Shares of ANGO stock traded down $0.33 on Friday, reaching $9.50. The company had a trading volume of 539,146 shares, compared to its average volume of 571,638. The stock has a market cap of $384.43 million, a PE ratio of -1.69 and a beta of 0.56. The company has a 50-day moving average of $10.41 and a 200-day moving average of $8.80. AngioDynamics, Inc. has a 12 month low of $5.47 and a 12 month high of $13.50.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last issued its earnings results on Wednesday, January 8th. The medical instruments supplier reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.07. The firm had revenue of $72.90 million during the quarter, compared to the consensus estimate of $70.93 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business's quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.05) earnings per share. Sell-side analysts anticipate that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.